Literature DB >> 8620609

Altered ventricular and myocyte response to angiotensin II in pacing-induced heart failure.

C P Cheng1, M Suzuki, N Ohte, M Ohno, Z M Wang, W C Little.   

Abstract

Alterations in the cardiac response to angiotensin II (Ang II) may contribute to the functional impairment in tachycardia-induced heart failure (congestive heart failure [CHF]). Accordingly, we studied the response to Ang II in eight conscious instrumented dogs before and after inducing CHF. Left ventricular (LV) performance was assessed by measuring LV pressure and LV volume. Isolated myocyte function was evaluated using computer-assessed videomicroscopy. In conscious animals before CHF, Ang II produced a load-dependent slowing of the time constant of LV relaxation (tau) and did not depress intact LV contractile function. After CHF, although Ang II produced a similar increase in LV systolic pressure, the increases in LV diastolic pressure and time constant tau were much greater, and contractile performance was depressed. These changes persisted when the elevation of end-systolic pressure was prevented by nitroprusside. Similar changes were also present after autonomic blockade. In isolated myocytes, before CHF, Ang II (10(-6) mol/L) produced a slight positive inotropic effect. In contrast, after CHF, Ang II produced a negative inotropic effect and slowed the rate of relengthening. The effects in the intact LV and myocytes were reversed by an Ang II AT1 receptor blocker (losartan). We conclude that pacing-induced CHF alters the LV and myocyte response to Ang II, so that Ang II produces direct depressions in intact LV contraction, relaxation, and filling and exacerbates myocyte contractile dysfunction. These effects are mediated through the activation of AT1 receptors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8620609     DOI: 10.1161/01.res.78.5.880

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  19 in total

1.  Up-regulation and functional effect of cardiac β3-adrenoreceptors in alcoholic monkeys.

Authors:  Heng-Jie Cheng; Kathleen A Grant; Qing-Hua Han; James B Daunais; David P Friedman; Satoshi Masutani; William C Little; Che-Ping Cheng
Journal:  Alcohol Clin Exp Res       Date:  2010-05-12       Impact factor: 3.455

2.  Levosimendan restores the positive force-frequency relation in heart failure.

Authors:  Satoshi Masutani; Heng-Jie Cheng; Hideo Tachibana; William C Little; Che-Ping Cheng
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-05-13       Impact factor: 4.733

3.  Cellular basis of angiotensin-(1-7)-induced augmentation of left ventricular functional performance in heart failure.

Authors:  Xiaowei Zhang; Heng-Jie Cheng; Peng Zhou; Dalane W Kitzman; Carlos M Ferrario; Wei-Min Li; Che Ping Cheng
Journal:  Int J Cardiol       Date:  2017-01-10       Impact factor: 4.164

Review 4.  Role of estrogen in diastolic dysfunction.

Authors:  Zhuo Zhao; Hao Wang; Jewell A Jessup; Sarah H Lindsey; Mark C Chappell; Leanne Groban
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-01-10       Impact factor: 4.733

5.  Myocardial performance and its acute response to angiotensin II infusion in fetal sheep adapted to chronic anemia.

Authors:  Leah S Bernard; Jason N Hashima; A Roger Hohimer; David J Sahn; Muhammad Ashraf; Olli Vuolteenaho; Lowell E Davis; Juha Rasanen
Journal:  Reprod Sci       Date:  2011-11-03       Impact factor: 3.060

Review 6.  Diastolic dysfunction as a cause of exercise intolerance.

Authors:  W C Little; D W Kitzman; C P Cheng
Journal:  Heart Fail Rev       Date:  2000-12       Impact factor: 4.214

7.  Overexpression myocardial inducible nitric oxide synthase exacerbates cardiac dysfunction and beta-adrenergic desensitization in experimental hypothyroidism.

Authors:  Qun Shao; Heng-Jie Cheng; Michael F Callahan; Dalane W Kitzman; Wei-Min Li; Che Ping Cheng
Journal:  Int J Cardiol       Date:  2015-11-06       Impact factor: 4.164

Review 8.  Pacing-induced cardiomyopathy: pathophysiological insights through matrix metalloproteinases.

Authors:  Fozia Z Ahmed; Rajdeep S Khattar; Amir M Zaidi; Ludwig Neyses; Delvac Oceandy; Mamas Mamas
Journal:  Heart Fail Rev       Date:  2014-09       Impact factor: 4.214

9.  β3-Adrenergic receptor antagonist improves exercise performance in pacing-induced heart failure.

Authors:  Satoshi Masutani; Heng-Jie Cheng; Atsushi Morimoto; Hiroshi Hasegawa; Qing-Hua Han; William C Little; Che Ping Cheng
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-07-19       Impact factor: 4.733

10.  A randomized, double-blind, placebo-controlled study to determine the effects of valsartan on exercise time in patients with symptomatic heart failure with preserved ejection fraction.

Authors:  Hari K Parthasarathy; Burkert Pieske; Marianne Weisskopf; Chris D Andrews; Patrick Brunel; Allan D Struthers; Thomas M MacDonald
Journal:  Eur J Heart Fail       Date:  2009-10       Impact factor: 15.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.